Bio-Path Holdings, Inc.
BPTH · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | -$0 | $0 | -$0 |
| % Margin | – | – | 50% | – |
| R&D Expenses | $4 | $2 | $2 | $1 |
| G&A Expenses | $1 | $1 | $1 | $1 |
| SG&A Expenses | $1 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$0 | $0 | $0 |
| Operating Expenses | $5 | $3 | $3 | $3 |
| Operating Income | -$5 | -$3 | -$3 | -$3 |
| % Margin | – | – | -1,661.4% | – |
| Other Income/Exp. Net | -$0 | $0 | -$0 | $1 |
| Pre-Tax Income | -$5 | -$3 | -$3 | -$2 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$5 | -$3 | -$3 | -$2 |
| % Margin | – | – | -1,742.4% | – |
| EPS | -0.55 | -0.4 | -1.15 | -0.7 |
| % Growth | -37.5% | 65.2% | -64.3% | – |
| EPS Diluted | -0.55 | -0.4 | -1.15 | -0.7 |
| Weighted Avg Shares Out | 8 | 7 | 2 | 3 |
| Weighted Avg Shares Out Dil | 8 | 7 | 2 | 3 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$5 | -$3 | -$3 | -$3 |
| % Margin | – | – | -1,631.6% | – |